Hts Biochemie-innovationen Gmbh

What Hts Biochemie-innovationen Gmbh does

HTS Biochemie-Innovationen GmbH is a Hamburg-based specialty chemicals supplier founded in 2012 that manufactures and distributes screening compound libraries, building blocks, and custom synthesis services for pharmaceutical, biotechnology, agricultural, and academic research customers worldwide. The company operates from a Hamburg headquarters and a dedicated production site at the ChemiePark Bitterfeld-Wolfen, combining corporate, scientific, and manufacturing functions.

The company's core technology centers on organic synthesis and medicinal chemistry. It maintains a stock inventory of approximately 300,000 drug-like and lead-like screening compounds and 60,000 building blocks, complemented by virtual collections of roughly 1,000,000 compounds each that can be synthesized on demand. Additional product lines include custom scaffold libraries drawn from an estimated 10,000 proprietary scaffolds, lead-like libraries designed around modern drug-like parameters, a fluorine-containing chemistry library exceeding 2,000 compounds, and a natural compounds collection of approximately 200 stock plus 1,000 virtual compounds. All stock compounds are validated at 90%+ purity via NMR and/or LC-MS, with custom projects scaled from 0.1 mg to 1,000 g. The company states that most compounds and scaffolds are not available from other commercial sources.

HTS generates revenue through one-time compound sales from stock and virtual catalogs priced per unit (in EUR or USD, EXW, 30-day net terms) and through individually-quoted contract research and custom synthesis projects. Distribution is direct via email purchase orders worldwide, with Key Organics Ltd serving as a UK distribution partner holding significant local inventory. Marketing is conducted through the company website and downloadable catalogs in English and German. The company has not disclosed funding rounds, revenue, or headcount data.

Name

Hts Biochemie-innovationen Gmbh

Legal name

HTS Biochemie – Innovationen GmbH

Website

https://hts-biochemie.de

Company type

Private

Founded year

2012

Operating status

Operating

Headcount range

11–50 employees

Short description

HTS Biochemie-Innovationen GmbH is a Hamburg-based specialty chemicals supplier founded in 2012 that provides proprietary screening compound libraries, building blocks, and custom synthesis services to pharmaceutical, biotechnology, agricultural, and academic research customers worldwide.

Ownership category

akta.pro rank

Product category

Chemical Compound Libraries for Drug Discovery

NAICS

Medicinal and Botanical Manufacturing (325411), Pharmaceutical and Medicine Manufacturing (32541), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Medicinal Chemicals & Botanical Products (2833), Services-Commercial Physical & Biological Research (8731), Industrial Organic Chemicals (2860)

akta.pro primary industry

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)

akta.pro secondary industries

High-Throughput Screening & Assay Platforms (HTS/HCS, phenotypic screening) (HLAAAIAA), Library & Diversity Generation Platforms (display libraries, DNA-encoded libraries for biologics, variant libraries) (HLAAAIAL)

Keywords

• Screening compounds
• Building blocks chemistry
• Custom synthesis services
• Drug discovery libraries
• Medicinal chemistry

Headquarters

HQ city

Hamburg

HQ country

Germany

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Screening Compound Sales: One-time sale of screening compounds from stock inventory (300,000+ compounds) and virtual compounds synthesized on demand. Compounds sold in quantities from 0.5 mg to 500 mg with minimum 90% purity guaranteed.
2. Building Block Sales: Sale of building block compounds from stock (~60,000) and virtual collection (~1,000,000). Stock quantities range from 0.5 to 500 g per compound. Revenue recognized per transaction based on quantity and compound type.
3. Custom Scaffold Library Projects: Custom synthesis services for scaffold libraries and compound libraries tailored to specific customer requirements. Terms, conditions, and pricing negotiated individually for each project. Compounds exclusively available from HTS only.
4. Contract Research & Custom Synthesis: Custom synthesis services including development of proprietary chemistries, scale-up, and medicinal chemistry. Projects managed by scientific and business professionals with delivery scales from 0.1 mg to 1000 g.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels2 records

Core offering

HTS Biochemie designs, synthesizes, and supplies chemical compound libraries for drug discovery, including stock and virtual screening compounds, building blocks, scaffold libraries, lead-like libraries, fluorine-containing compounds, and natural products. The company also provides contract research and custom synthesis services for pharmaceutical, biotechnology, and agricultural customers worldwide.

Product overview

HTS Biochemie-Innovationen GmbH offers a portfolio of chemical compound libraries and custom synthesis services for pharmaceutical, agricultural, and biotechnology industries. The product line consists of six distinct offerings: Screening Compounds (stock collection of ~300,000 plus virtual collection of ~1,000,000 drug-like and lead-like compounds), Building Blocks (~60,000 stock plus ~1,000,000 virtual compounds), Scaffold Libraries (custom synthesis based on customer requirements), Lead-like Libraries (designed to modern drug-like parameters), Fluorine Containing Chemistry (~2,000+ compounds), and Natural Compounds (~200 stock plus ~1,000 virtual). All stock compounds are validated at 90%+ purity by NMR and/or LC-MS. Virtual compounds are synthesized on demand with timelines of 1 week to 2 months. The company also provides custom synthesis services with approximately 10,000 scaffolds available for selection.

Differentiator

Problem solved

Functional benefit

Products and services

• Screening Compounds Stock collection of approximately 300,000 drug-like and lead-like screening compounds plus virtual collection of approximately 1,000,000 compounds available for on-demand synthesis, supplied in 0.5 mg to 500 mg quantities at 90%+ purity validated by NMR and/or LC-MS.
• Building Blocks Stock collection of approximately 60,000 building block compounds plus a virtual collection of about 1,000,000 compounds, available in 0.5 to 500 g quantities at 90%+ purity, featuring wide diversity by compound classes and functional groups.
• Scaffold Libraries Custom-developed scaffold and library synthesis services based on individual customer requirements, with an estimated 10,000 scaffolds available for selection and exclusive availability from HTS, including isotope scaffold capabilities.
• Lead-like Libraries Libraries of compounds designed to meet modern drug-like parameters including logP criteria, molecular weight, and molecular complexity.
• Fluorine Containing Chemistry Specialized library of more than 2,000 fluorine-containing compounds leveraging the unique properties of fluorinated molecules for bioactivity in drug discovery.
• Natural Compounds Stock collection of approximately 200 natural compounds plus a virtual collection of about 1,000 natural compounds, including nature molecule derivatives and exclusive custom synthesis projects.
• Custom Synthesis and Contract Research Services Custom synthesis services including development of proprietary chemistries, scale-up, and medicinal chemistry, with delivery scales from 0.1 mg to 1000 g and flexible library formats of 20-500 analogs per scaffold.

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

One partnership is on record.

• Key Organics LtdcoreChannel Partner/ Reseller/ DistributorKey Organics Ltd serves as the UK distributor for HTS Biochemie products. Products are listed and sold through this partnership with significant stock holdings maintained in the UK for rapid delivery to UK-based pharmaceutical, biotech, and research customers. This partnership enables local sales and support for the UK market.

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• ChemDiv: US-based supplier of screening libraries, building blocks, and integrated drug discovery services to pharma and biotech customers. Operates one of the largest commercial compound collections worldwide and competes head-to-head with HTS Biochemie for HTS and medicinal chemistry programs.
• InterBioScreen: Russia-based provider of natural and synthetic compound libraries, focused on screening collections and custom synthesis. Comparable in niche specialization (natural products, screening libraries) and pharma/biotech customer base.
• OTAVA Chemicals: Ukraine- and Canada-based supplier of screening compounds, building blocks, and specialty chemical libraries including fluorinated and natural-product-derived collections. Closely mirrors HTS Biochemie's catalog structure and customer profile.
• Life Chemicals: Canada- and Ukraine-based provider of screening compound libraries, building blocks, and custom synthesis for drug discovery. Comparable in offering structure, customer segments, and target applications to HTS Biochemie, with similar emphasis on exclusive chemical matter.
• Combi-Blocks: US-based manufacturer and supplier of screening compounds, building blocks, and custom synthesis services. Directly comparable in catalog scope and pharma/biotech customer base, with overlapping fluorine and heterocyclic chemistry capabilities.
• ASINEX: Russia-based provider of screening compound libraries, building blocks, and custom synthesis with a focus on novel chemical scaffolds. Comparable in exclusive compound positioning and medicinal chemistry service offerings to HTS Biochemie.
• Enamine: Ukraine-headquartered provider of screening compound libraries, building blocks, and custom synthesis serving global pharma and biotech. Directly comparable to HTS Biochemie in product mix, customer base, and scale-up capabilities, but with a substantially larger catalog.
• Princeton BioMolecular Research: US-based supplier of screening libraries, building blocks, and custom chemistry services to pharma, biotech, and academic customers. Directly comparable in product categories, distribution channels, and target use cases for HTS and lead optimization.
• Key Organics Ltd: UK-based supplier of screening compounds, building blocks, and chemical intermediates with a B2B catalog and custom synthesis offering. While also HTS Biochemie's UK distributor, it competes as an independent peer in compound supply across the same European customer base.

Broad incumbents

• Sigma-Aldrich (Merck): Global life-science tools and chemical supply incumbent offering an extensive catalog of reagents, building blocks, and screening compounds. Overlaps with HTS Biochemie in chemical supply and pharma/biotech procurement channels, but as a much broader portfolio player rather than a niche specialist.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/biochemie-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hts Biochemie-innovationen Gmbh